Cargando…
Recommender Systems in Antiviral Drug Discovery
[Image: see text] Recommender systems (RSs), which underwent rapid development and had an enormous impact on e-commerce, have the potential to become useful tools for drug discovery. In this paper, we applied RS methods for the prediction of the antiviral activity class (active/inactive) for compoun...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315437/ https://www.ncbi.nlm.nih.gov/pubmed/32632398 http://dx.doi.org/10.1021/acsomega.0c00857 |
_version_ | 1783550256363864064 |
---|---|
author | Sosnina, Ekaterina A. Sosnin, Sergey Nikitina, Anastasia A. Nazarov, Ivan Osolodkin, Dmitry I. Fedorov, Maxim V. |
author_facet | Sosnina, Ekaterina A. Sosnin, Sergey Nikitina, Anastasia A. Nazarov, Ivan Osolodkin, Dmitry I. Fedorov, Maxim V. |
author_sort | Sosnina, Ekaterina A. |
collection | PubMed |
description | [Image: see text] Recommender systems (RSs), which underwent rapid development and had an enormous impact on e-commerce, have the potential to become useful tools for drug discovery. In this paper, we applied RS methods for the prediction of the antiviral activity class (active/inactive) for compounds extracted from ChEMBL. Two main RS approaches were applied: collaborative filtering (Surprise implementation) and content-based filtering (sparse-group inductive matrix completion (SGIMC) method). The effectiveness of RS approaches was investigated for prediction of antiviral activity classes (“interactions”) for compounds and viruses, for which some of their interactions with other viruses or compounds are known, and for prediction of interaction profiles for new compounds. Both approaches achieved relatively good prediction quality for binary classification of individual interactions and compound profiles, as quantified by cross-validation and external validation receiver operating characteristic (ROC) score >0.9. Thus, even simple recommender systems may serve as an effective tool in antiviral drug discovery. |
format | Online Article Text |
id | pubmed-7315437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-73154372020-06-25 Recommender Systems in Antiviral Drug Discovery Sosnina, Ekaterina A. Sosnin, Sergey Nikitina, Anastasia A. Nazarov, Ivan Osolodkin, Dmitry I. Fedorov, Maxim V. ACS Omega [Image: see text] Recommender systems (RSs), which underwent rapid development and had an enormous impact on e-commerce, have the potential to become useful tools for drug discovery. In this paper, we applied RS methods for the prediction of the antiviral activity class (active/inactive) for compounds extracted from ChEMBL. Two main RS approaches were applied: collaborative filtering (Surprise implementation) and content-based filtering (sparse-group inductive matrix completion (SGIMC) method). The effectiveness of RS approaches was investigated for prediction of antiviral activity classes (“interactions”) for compounds and viruses, for which some of their interactions with other viruses or compounds are known, and for prediction of interaction profiles for new compounds. Both approaches achieved relatively good prediction quality for binary classification of individual interactions and compound profiles, as quantified by cross-validation and external validation receiver operating characteristic (ROC) score >0.9. Thus, even simple recommender systems may serve as an effective tool in antiviral drug discovery. American Chemical Society 2020-06-21 /pmc/articles/PMC7315437/ /pubmed/32632398 http://dx.doi.org/10.1021/acsomega.0c00857 Text en Copyright © 2020 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. |
spellingShingle | Sosnina, Ekaterina A. Sosnin, Sergey Nikitina, Anastasia A. Nazarov, Ivan Osolodkin, Dmitry I. Fedorov, Maxim V. Recommender Systems in Antiviral Drug Discovery |
title | Recommender Systems in Antiviral Drug Discovery |
title_full | Recommender Systems in Antiviral Drug Discovery |
title_fullStr | Recommender Systems in Antiviral Drug Discovery |
title_full_unstemmed | Recommender Systems in Antiviral Drug Discovery |
title_short | Recommender Systems in Antiviral Drug Discovery |
title_sort | recommender systems in antiviral drug discovery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315437/ https://www.ncbi.nlm.nih.gov/pubmed/32632398 http://dx.doi.org/10.1021/acsomega.0c00857 |
work_keys_str_mv | AT sosninaekaterinaa recommendersystemsinantiviraldrugdiscovery AT sosninsergey recommendersystemsinantiviraldrugdiscovery AT nikitinaanastasiaa recommendersystemsinantiviraldrugdiscovery AT nazarovivan recommendersystemsinantiviraldrugdiscovery AT osolodkindmitryi recommendersystemsinantiviraldrugdiscovery AT fedorovmaximv recommendersystemsinantiviraldrugdiscovery |